This review provides a comprehensive synthesis of reported MTC cases involving CEA and Ctn, systematically evaluating the impact of perioperative fluctuations in these biomarkers on diagnosis, treatment decisions, and prognosis. The gene discussed is CEACAM5; the disease is medullary thyroid gland carcinoma.